Studies suggest infusion of blood vessel cells may contribute to organ regeneration in the future
10/11/2013
Damaged or diseased organs may someday be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants, according to scientists at Weill Cornell Medical College...
New method for improving cord blood transplant success
10/11/2013
Starting with a discovery in zebrafish in 2007, Harvard Stem Cell Institute (HSCI) researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that has the potential to improve the success of blood stem cell transplantation...
Sunscreen shields important anti-cancer gene
10/10/2013
Researchers who conducted the world's first study to assess the molecular impact of sunscreen found it offers 100% protection against all three types of skin cancer - basal cell carcinoma, squamous cell carcinoma and malignant melanoma. They also found sunscreen prevents damage to a key anti-cancer gene known as p53...
Adaptive Biotechnologies study reveals homogeneous immune repertoire in solid tumors
10/10/2013
Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, has announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor...
Epigem secures 700,000 Euros of European funding to help anaemia sufferers
10/10/2013
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project...
Sunscreen shields important anti-cancer gene
10/10/2013
Researchers who conducted the world's first study to assess the molecular impact of sunscreen found it offers 100% protection against all three types of skin cancer - basal cell carcinoma, squamous cell carcinoma and malignant melanoma. They also found sunscreen prevents damage to a key anti-cancer gene known as p53...
Combination of anemia and high altitude negatively impacts children with pneumonia
10/10/2013
Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 me...
Adaptive Biotechnologies study reveals homogeneous immune repertoire in solid tumors
10/10/2013
Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, has announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor...
Epigem secures 700,000 Euros of European funding to help anaemia sufferers
10/10/2013
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project...
PET imaging shown to be effective in predicting lung cancer outcomes
10/10/2013
Advanced imaging with Positron Emission Tomography (PET) scan shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research recently published online in the Journal of Clinical Oncology...